United States Healthcare Equipment & Supplies

Avanos Medical Inc (AVNS)

Track

The most recent insider trading activity at Avanos Medical Inc occurred on November 18, 2025, involving multiple sell transactions by SVP and Chief Commercial Officer Holbrook Kerr. As these transactions occurred more than three months ago, no assessment of current stock performance or price context is provided.
Ticker: AVNS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Avanos Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 18 Nov 2025
Value US$4,442,466.25 | Price 470.14 | Shares 48,474 (-42.4%)
Sale 18 Nov 2025
Value US$1,823,021.54 | Price 170.55 | Shares 44,938 (+27.1%)
Sale 18 Nov 2025
Value US$1,100.50 | Price 11.01 | Shares 100 (-0.1%)
Sale 18 Nov 2025
Value US$152,174.00 | Price 11.00 | Shares 13,834 (-14.0%)
Proposed sale 18 Nov 2025
Value US$165,014.21 | Price 11.00 | Shares 15,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
48,474 -42.4%
470.14
US$4,442,466 		48,474 -42.4% 470.14 US$4,442,466
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
44,938 +27.1%
170.55
US$1,823,022 		44,938 +27.1% 170.55 US$1,823,022
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
49,308 -8.0%
266.31
US$4,991,184 		49,308 -8.0% 266.31 US$4,991,184
2025-11-19 2025-11-18 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
13,834 -14.0%
11.00
US$152,174 		13,834 -14.0% 11.00 US$152,174
2025-11-18 2025-11-18 PrS Proposed sale
2.0
Holbrook Kerr

Former Officer

Officer
15,000
11.00
US$165,014 		15,000 11.00 US$165,014
2025-08-15 2025-08-13 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
40,000 +inf%
11.00
US$439,800 		40,000 +inf% 11.00 US$439,800
2025-08-15 2025-08-13 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
20,000 +27.9%
10.98
US$219,500 		20,000 +27.9% 10.98 US$219,500
2025-03-10 2025-03-06 S Sale
2.0
Holbrook Kerr

SVP, Chief Commercial Officer

Officer
7,000 -7.9%
15.25
US$106,778 		7,000 -7.9% 15.25 US$106,778
2025-03-06 2025-03-06 PrS Proposed sale
2.0
Holbrook Kerr

Officer

Officer
7,000
15.25
US$106,780 		7,000 15.25 US$106,780
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
110 -0.1%
19.16
US$2,108 		110 -0.1% 19.16 US$2,108
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
808 -0.5%
19.15
US$15,473 		808 -0.5% 19.15 US$15,473
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
337 -0.2%
19.14
US$6,450 		337 -0.2% 19.14 US$6,450
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
2,231 -1.4%
19.13
US$42,679 		2,231 -1.4% 19.13 US$42,679
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
714 -0.5%
19.12
US$13,652 		714 -0.5% 19.12 US$13,652
2024-03-15 2024-03-14 S Sale
2.6
Greiner Michael

SVP - Chief Financial Officer

Officer
3,800 -2.4%
19.11
US$72,618 		3,800 -2.4% 19.11 US$72,618
2024-03-14 2024-03-14 PrS Proposed sale
2.6
Greiner Michael

Officer

Officer
8,000
19.12
US$152,980 		8,000 19.12 US$152,980
2024-03-11 2024-03-11 B Purchase
1.1
Shimer Julie Ann
Non-Executive Director
500 +1.0%
19.85
US$9,925 		500 +1.0% 19.85 US$9,925
2020-05-11 2020-05-08 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
5,000 +16.8%
28.50
US$142,500 		5,000 +16.8% 28.50 US$142,500
2020-05-11 2020-05-08 B Purchase
3.8
BLACKFORD GARY
Non-Executive Director
5,000 +20.1%
29.00
US$145,000 		5,000 +20.1% 29.00 US$145,000
2019-06-03 2019-05-30 B Purchase
1.9
Woody Joseph Fralin

Chief Executive Officer

Executive Director
3,500 +14.0%
39.95
US$139,825 		3,500 +14.0% 39.95 US$139,825
2018-11-29 2018-11-28 B Purchase Woody Joseph Fralin

Chief Executive Officer

Executive Director
3,500 +16.2%
43.35
US$151,725 		3,500 +16.2% 43.35 US$151,725
2018-11-28 2018-11-27 B Purchase Voskuil Steven E

SVP, Chief Financial Officer

Officer
2,000 +9.9%
43.74
US$87,470 		2,000 +9.9% 43.74 US$87,470
2018-11-20 2018-11-19 B Purchase Wesley John W

SVP, General Counsel

Officer
1,000 +15.4%
47.48
US$47,480 		1,000 +15.4% 47.48 US$47,480
2015-09-08 2015-09-04 B Purchase ABERNATHY ROBERT E

Chairman and CEO

Executive Director
10,000 +14.3%
31.06
US$310,600 		10,000 +14.3% 31.06 US$310,600
2015-09-02 2015-09-01 B Purchase Voskuil Steven E

SVP, Chief Financial Officer

Officer
1,000 +3.6%
30.00
US$30,000 		1,000 +3.6% 30.00 US$30,000
Explore more

More insider trading research around Avanos Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America